MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

20 May 2026 Evaluate
A decrease of about -35.72% in the sales to Rs. 37409.00 millions was observed for the quarter ended March 2026. The sales stood at Rs. 58196.00 millions during the similar quarter previous year.Profit after Tax for the quarter ended March 2026 saw a decline of -38.80% from Rs. 28137.00 millions to Rs. 17220.00  millions.The company reported a degrowth in operating Profit to 24842.00 millions from 39581.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 37409.00 58196.00 -35.72 114840.00 151163.00 -24.03 114840.00 151163.00 -24.03
Other Income 11430.00 1854.00 516.50 28962.00 9058.00 219.74 28962.00 9058.00 219.74
PBIDT 24842.00 39581.00 -37.24 55929.00 84325.00 -33.67 55929.00 84325.00 -33.67
Interest 1155.00 1554.00 -25.68 4829.00 4639.00 4.10 4829.00 4639.00 4.10
PBDT 22619.00 38027.00 -40.52 49431.00 79686.00 -37.97 49431.00 79686.00 -37.97
Depreciation 1509.00 1280.00 17.89 5612.00 5239.00 7.12 5612.00 5239.00 7.12
PBT 21110.00 36747.00 -42.55 43819.00 74447.00 -41.14 43819.00 74447.00 -41.14
TAX 3890.00 8610.00 -54.82 8221.00 16698.00 -50.77 8221.00 16698.00 -50.77
Deferred Tax -577.00 345.00 -267.25 -777.00 873.00 -189.00 -777.00 873.00 -189.00
PAT 17220.00 28137.00 -38.80 35598.00 57749.00 -38.36 35598.00 57749.00 -38.36
Equity 1006.00 1006.00 0.00 1006.00 1006.00 0.00 1006.00 1006.00 0.00
PBIDTM(%) 66.41 68.01 -2.36 48.70 55.78 -12.70 48.70 55.78 -12.70
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..